WallStreetZenWallStreetZen

NASDAQ: ASND
Ascendis Pharma A Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ASND past revenue growth

How has ASND's revenue growth performed historically?
Company
444.36%
Industry
144.63%
Market
17.55%
ASND's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ASND's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ASND's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ASND earnings and revenue history

Current Revenue
$296.4M
Current Earnings
-$534.9M
Current Profit Margin
-180.5%

ASND Return on Equity

Current Company
-14,914.7%
Current Industry
-63.5%
Current Market
188%
ASND's Return on Equity (-14,914.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ASND announces earnings.

ASND Return on Assets

Current Company
-55.2%
Current Industry
2.9%
ASND is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ASND Return on Capital Employed

Current Company
-68.46%
Current Industry
19.5%
ASND's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ASND vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ASND$286.79M-$442.12M-$517.68M+89.39%N/A
CERE$0.00-$416.15M-$432.84MN/AN/A
VKTX$0.00-$93.43M-$93.72MN/AN/A
LEGN$285.14M-$477.87M-$518.25M+42.15%N/A
EXEL$1.83B$312.21M$207.77M+16.47%-22.47%
View Top Biotech Stocks

ASND earnings dates

Next earnings date
May 2, 2024

Ascendis Pharma A Earnings & Revenue FAQ

What were ASND's earnings last quarter?

On Invalid Date, Ascendis Pharma A (NASDAQ: ASND) reported Q4 2023 earnings per share (EPS) of -$1.70, up 56.81% year over year. Total Ascendis Pharma A earnings for the quarter were -$96.53 million. In the same quarter last year, Ascendis Pharma A's earnings per share (EPS) was -$3.94.

If you're new to stock investing, here's how to buy Ascendis Pharma A stock.

What was ASND's earnings growth in the past year?

As of Q2 2024, Ascendis Pharma A's earnings has grown year over year. Ascendis Pharma A's earnings in the past year totalled -$517.68 million.

What is ASND's earnings date?

Ascendis Pharma A's earnings date is Invalid Date. Add ASND to your watchlist to be reminded of ASND's next earnings announcement.

What was ASND's revenue last quarter?

On Invalid Date, Ascendis Pharma A (NASDAQ: ASND) reported Q4 2023 revenue of $153.00 million up 528.15% year over year. In the same quarter last year, Ascendis Pharma A's revenue was $24.36 million.

What was ASND's revenue growth in the past year?

As of Q2 2024, Ascendis Pharma A's revenue has grown 444.36% year over year. This is 299.73 percentage points higher than the US Biotechnology industry revenue growth rate of 144.63%. Ascendis Pharma A's revenue in the past year totalled $286.79 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.